Hone Health
Hormone optimisation platform with real biomarker testing and physician-guided protocols, for men and women.
Menopause and women's hormone care has been chronically underserved. Telehealth-first platforms now offer estradiol, progesterone, vaginal estrogen, and DHEA at significantly lower price points than legacy clinics.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Women's telehealth has expanded rapidly to address historically underserved conditions: menopause, perimenopause, female pattern hair loss, PCOS, and sexual health. Hormone replacement therapy (HRT) — estradiol, progesterone, and testosterone — is the primary pharmacological intervention for menopausal symptoms and is increasingly available through telehealth platforms.
The Women's Health Initiative (WHI) study in 2002 created widespread fear about HRT that subsequent research has largely refuted for younger, recently menopausal women. Current evidence supports HRT for women under 60 or within 10 years of menopause onset who have bothersome symptoms, with a favourable risk-benefit profile for most women in this group.
Online women's health platforms offer bioidentical hormone therapy (estradiol, progesterone, DHEA), compounded formulations, and non-hormonal alternatives. Pricing is significantly lower than legacy OB/GYN or menopause specialist practices, making telehealth the most accessible entry point for most women.
FDA-approved bioidentical HRT includes estradiol patches (Vivelle-Dot, Climara), gels (Divigel, EstroGel), sprays (Evamist), and oral micronised progesterone (Prometrium). These are structurally identical to endogenous hormones and have the most robust safety data. Most online women's health platforms can prescribe these.
Compounded bioidentical HRT (cBHRT) is prepared by compounding pharmacies to custom doses and delivery routes. It is popular among patients who want non-standard doses or combinations, but it lacks the standardised quality controls of FDA-approved products. The Endocrine Society does not recommend cBHRT over FDA-approved options for most patients.
Vaginal estrogen (Vagifem, Imvexxy, Estring) treats genitourinary syndrome of menopause (GSM) with minimal systemic absorption. It is safe for most women including those with a history of breast cancer. Ospemifene (Osphena) is a non-hormonal oral alternative for dyspareunia.
Published price terms at the lower and higher listed rates. Medication, consult, shipping, and plan-length conditions vary; review the billing terms and choose a sort order below.
Recorded price-check dates: 15 June 2026. Per-provider dates below; these are not a guarantee of today's checkout price.
Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.
4 providers · Trustpilot scores are customer opinions, not treatment results.
| Provider & billing terms | Lower listed rate | Higher listed rate | Pharmacy | Reviews & price check | Actions |
|---|---|---|---|---|---|
| Hone Health Hone's $25/mo figure is the membership and ongoing physician oversight fee: biomarker testing kits and the actual TRT, GLP-1, or longevity medications are billed on top. Always estimate the full all-in monthly cost (membership + lab + medication) before subscribing. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $25/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 4.8/5 12,311 reviews 15 June 2026 | Go Hone HealthRead full review |
| Gala Health Combined GLP-1 + HRT plans bundle medication and provider oversight in a single monthly price. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 4.6/5 3,986 reviews 15 June 2026 | Go Gala HealthRead full review |
| Tonik Tonik bundles physician oversight, lab work, and concierge support into the monthly subscription. Medications are passed through at clinic-published rates with no markup, but lab and visit fees can add up at intake. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $225/mo | Higher listed rateUp to $449/mo | PharmacyNot disclosed | 4.3/5 9 reviews 15 June 2026 | Go TonikRead full review |
| Inner Balance Inner Balance uses a quiz-to-consultation model; pricing is disclosed after a clinician review. Oestra® (HRT/hormonal imbalance), Libida™ (libido), NAD+ (longevity), and BodyMatched™ (anti-aging skincare) are the four core offerings. HSA/FSA eligible. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $150/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 2.7/5 19 reviews 15 June 2026 | Go Inner BalanceRead full review |
Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →
Hormone optimisation platform with real biomarker testing and physician-guided protocols, for men and women.
Women-focused telehealth combining compounded GLP-1 weight loss with HRT support.
Lab-driven telehealth clinic combining GLP-1, TRT, BHRT, and peptide longevity protocols.
Women's telehealth clinic offering bioidentical HRT, libido support, NAD+ longevity, and prescription skincare, all founded by a board-certified women's health specialist.
15-year concierge TRT and hormone optimization clinic with a 4.8/5 Trustpilot score from 3,900+ verified patients.
Affordable subscription telehealth with one of the largest compounded formularies in the industry.
Wide compounded and brand-name catalog covering weight loss, anti-aging, and hair growth without insurance.
Doctor-guided GLP-1 program with both injectable and tablet options across multiple categories.
A physician-founded multi-category telehealth platform covering GLP-1, TRT, peptides, and women's hormones — reviewed by Forbes, US News, and Yahoo Finance.
Online women’s-health platform centered on menopause and hormone care with related wellness services.
Listed alphabetically with their published price range. Open a review for pricing details, pros and cons, and terms.
| Provider | Best for | Published price | Editor score |
|---|---|---|---|
| GoodRx Care | FDA-approved GLP-1s with membership care | From $188 – $188/mo | 4.0 / 5 |
| Hers | GLP-1, hair, skincare, and menopause care for women | From $149 – $449/mo | 4.4 / 5 |
| JRNYS | GLP-1 and sexual wellness with insurance navigation | From $89 – $299/mo | 4.2 / 5 |
| Lemonaid Health | Broad GLP-1 menu with ongoing care | From $248 – $248/mo | 4.0 / 5 |
| LifeMD | Multi-category care with Wegovy access | From $298 – $348/mo | 4.0 / 5 |
| Midi Health | Virtual menopause and hormone care | From $50 – $250/visit | 4.0 / 5 |
| Nurx | Broad virtual women’s-health care | From $0 – $125/mo | 4.0 / 5 |
Evidence rows reference published clinical trials and systematic reviews. HRT decisions should be individualised based on symptom severity, personal risk factors, and patient preference. This content does not constitute medical advice.
| Endpoint | Finding |
|---|---|
| Hot flash reduction with estradiol1 | 75–90% reduction in vasomotor symptom frequency with transdermal estradiol vs placebo |
| Bone density preservation2 | HRT prevents bone loss and reduces fracture risk by 25–35% in postmenopausal women |
| Breast cancer risk (WHI, combined HRT)2 | Hazard ratio 1.26 (95% CI 1.00–1.59) for invasive breast cancer with combined estrogen-progestogen HRT Absolute risk increase is small (~1 additional case/1,000 women/year). Estrogen-only HRT does not increase breast cancer risk. |
| Cardiovascular benefit (timing hypothesis)1 | HRT initiated within 10 years of menopause associated with reduced cardiovascular events in observational studies |
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
For most women under 60 or within 10 years of menopause onset, the benefits of HRT (symptom relief, bone protection, cardiovascular benefit) outweigh the risks. The absolute risk increase for breast cancer with combined estrogen-progestogen HRT is small (approximately 1 additional case per 1,000 women per year). Estrogen-only HRT (for women without a uterus) has a more favourable risk profile. Individual risk assessment with a clinician is essential.
Bioidentical hormones are structurally identical to hormones produced by the human body (estradiol, progesterone, testosterone). Synthetic hormones (conjugated equine estrogens, medroxyprogesterone acetate) have different molecular structures. FDA-approved bioidentical options (estradiol patches, micronised progesterone) have well-established safety data. Compounded bioidentical HRT has the same molecular structure but lacks standardised quality controls.
Online HRT platforms typically cost $15–$250/month all-in. Wisp offers some of the lowest prices ($15–$50/month for basic prescriptions). Winona ($27–$249/month) and Inner Balance ($150–$399/month) offer more comprehensive programs with ongoing clinician support. Compounded formulations cost more than FDA-approved generics.
Yes. All major online women's health platforms offer fully remote consultations. You complete a detailed medical history intake, a clinician reviews your information, and a prescription is issued if appropriate. Some platforms require baseline labs (FSH, estradiol, thyroid) before prescribing; others prescribe based on symptom history alone.
HRT is most effective for vasomotor symptoms (hot flashes, night sweats), genitourinary syndrome of menopause (vaginal dryness, painful intercourse), sleep disturbance, and mood changes related to estrogen decline. It also prevents bone loss and may reduce cardiovascular risk when started within 10 years of menopause.
For women's health, editors look at the HRT and non-hormonal options offered, the visit and follow-up model, and how clearly pricing is disclosed. Default order: providers with an eligible affiliate offer are listed first; within each group, order follows a 50/50 composite of our manual value score and a review-count-adjusted Trustpilot score, with trust and experience scores breaking ties. Scores are editorial judgments, not clinical assessments, and price checks are dated where shown.
Full methodology →We use Google Analytics 4 to understand how readers find and use RxNotebook. Analytics cookies are only set with your consent. We do not use advertising cookies. See our Cookie Policy and Privacy Policy for details.